<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39427928</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1527-3296</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>American journal of infection control</Title><ISOAbbreviation>Am J Infect Control</ISOAbbreviation></Journal><ArticleTitle>Comparative analysis of hospital-acquired and community-acquired infections at a tertiary hospital in China before and during COVID-19: A 7-year longitudinal study (2017-2023).</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0196-6553(24)00764-8</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajic.2024.10.009</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The COVID-19 pandemic profoundly influenced the dynamics of hospital-acquired infections (HAIs) and community-acquired infections (CAIs) across global healthcare systems. This 7-year longitudinal survey (2017-2023) assessed the point prevalence of HAIs and CAIs at a first-class tertiary hospital in China, both prior to and during the pandemic.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients were stratified into pre-pandemic and pandemic periods, as well as into stringent and relaxed infection prevention and control (IPC) phases, to compare the point prevalence of HAIs and CAIs. Multivariate logistic regression was employed to identify risk factors associated with HAIs.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 15,296 inpatients were assessed between 2017 and 2023. The overall point prevalence of HAIs was 1.50% (95% confidence interval [CI], 1.32%-1.71%), showing a significant downward trend (P = 0.021). Conversely, CAIs had an overall point prevalence of 24.49% (95% CI, 23.81%-25.18%) with a marked upward trend (P &lt; 0.001). Among patients receiving pathogen testing, the point prevalence of HAIs significantly declined during the pandemic (6.26% vs. 9.89%, P &lt; 0.001), particularly for respiratory HAIs (3.83% vs. 6.89%, P &lt; 0.001). The point prevalence of CAIs demonstrated a notable increase in 2023 compared to 2020-2022 among pathogen-tested patients (81.37% vs. 74.18%, P = 0.001). Multivariate analysis identified hospitalization during the pandemic as a protective factor against HAIs (adjusted odds ratio 0.49, 95% CI, 0.36-0.67).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The comprehensive IPC strategy implemented during the COVID-19 pandemic at this tertiary hospital significantly reduced the point prevalence of HAIs. However, CAIs exhibited a rising trend following the relaxation of COVID-19 IPC measures.</AbstractText><CopyrightInformation>Copyright Â© 2024 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Healthcare-Associated Infection Management, Tengzhou Central People's Hospital Affiliated to Xuzhou Medical University, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Jianing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Obstetrical department, Tengzhou Central People's Hospital Affiliated to Xuzhou Medical University, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Laboratory department, Tengzhou Central People's Hospital Affiliated to Xuzhou Medical University, Shandong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Ling</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Healthcare-Associated Infection Management, Tengzhou Central People's Hospital Affiliated to Xuzhou Medical University, Shandong Province, China. Electronic address: sl09629@outlook.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Infect Control</MedlineTA><NlmUniqueID>8004854</NlmUniqueID><ISSNLinking>0196-6553</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Community-acquired infection</Keyword><Keyword MajorTopicYN="N">Hospital-acquired infection</Keyword><Keyword MajorTopicYN="N">Multi-drug resistant organism</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>20</Day><Hour>19</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39427928</ArticleId><ArticleId IdType="doi">10.1016/j.ajic.2024.10.009</ArticleId><ArticleId IdType="pii">S0196-6553(24)00764-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle>